Nitrate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Nitrate
Accession Number
DB14049
Type
Small Molecule
Groups
Experimental, Investigational
Description
Not Available
Structure
Thumb
Synonyms
  • Nitrate ion
  • Nitrates
External IDs
N511
Categories
UNII
T93E9Y2844
CAS number
14797-55-8
Weight
Average: 62.0049
Monoisotopic: 61.987817871
Chemical Formula
NO3
InChI Key
NHNBFGGVMKEFGY-UHFFFAOYSA-N
InChI
InChI=1S/NO3/c2-1(3)4/q-1
IUPAC Name
nitrate
SMILES
[O-]N(=O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AnagrelideThe risk or severity of hypotension can be increased when Anagrelide is combined with Nitrate.
AvanafilThe risk or severity of hypotension can be increased when Avanafil is combined with Nitrate.
DapoxetineDapoxetine may increase the orthostatic hypotensive and hypotensive activities of Nitrate.
DipyridamoleThe risk or severity of hypotension can be increased when Dipyridamole is combined with Nitrate.
DoxofyllineThe risk or severity of hypotension can be increased when Doxofylline is combined with Nitrate.
EthanolEthanol may increase the hypotensive and vasodilatory activities of Nitrate.
FostamatinibThe risk or severity of hypotension can be increased when Fostamatinib is combined with Nitrate.
IbudilastThe risk or severity of hypotension can be increased when Ibudilast is combined with Nitrate.
MilrinoneThe risk or severity of hypotension can be increased when Milrinone is combined with Nitrate.
MirodenafilThe risk or severity of hypotension can be increased when Mirodenafil is combined with Nitrate.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Human Metabolome Database
HMDB0002878
ChemSpider
918
BindingDB
26988
ChEBI
17632
ChEMBL
CHEMBL186200
HET
NO3
Wikipedia
Nitrate
PDB Entries
1a4c / 1azr / 1bg0 / 1can / 1ch8 / 1cib / 1dkk / 1e5y / 1e5z / 1e67
show 656 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Not Yet RecruitingTreatmentHeart Failure With Normal Ejection Fraction / Pulmonary Heart Disease and Diseases of Pulmonary Circulation / Pulmonary Hypertension (PH)1
2RecruitingTreatmentAcute Cardiac Pulmonary Edema / Acute Heart Failure (AHF) / Heart Failure1
3CompletedPreventionOsteoporosis1
3CompletedTreatmentHypotensive Syncope1
Not AvailableRecruitingTreatmentNecrosis, Avascular, of Bone1
Not AvailableTerminatedTreatmentHeart Failure1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0.84ChemAxon
pKa (Strongest Basic)-9.9ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area66.2 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity8.35 m3·mol-1ChemAxon
Polarizability3.28 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
MS/MS Spectrum - Quattro_QQQ 10V, NegativeLC-MS/MSsplash10-03di-9000000000-62b6946f773f2794ce2b
MS/MS Spectrum - Quattro_QQQ 25V, NegativeLC-MS/MSsplash10-03dj-9000000000-b705d64f017cd9970bcb
MS/MS Spectrum - Quattro_QQQ 40V, NegativeLC-MS/MSsplash10-03di-9000000000-a03d650125e7c3c9631a
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of inorganic compounds known as non-metal nitrates. These are inorganic non-metallic compounds containing a nitrate as its largest oxoanion.
Kingdom
Inorganic compounds
Super Class
Homogeneous non-metal compounds
Class
Non-metal oxoanionic compounds
Sub Class
Non-metal nitrates
Direct Parent
Non-metal nitrates
Alternative Parents
Inorganic oxides
Substituents
Non-metal nitrate / Inorganic oxide
Molecular Framework
Not Available
External Descriptors
monovalent inorganic anion, nitrogen oxoanion, reactive nitrogen species (CHEBI:17632) / an anion (NITRATE)

Drug created on June 06, 2018 09:27 / Updated on May 01, 2019 11:56